by Summary:
Since dorzagliatin is supposed to “repair” patients’ damaged insulin regulating function, it can potentially be a “cure” for some patients, who will not need the drug after certain period of intake. Existing drugs only lower3 blood sugar when the need arises. SCMP Eric Ng - Why are investors offloading Hua Medicine stock which is close to launching a novel diabetes drug?
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Since dorzagliatin is supposed to “repair” patients’ damaged insulin regulating function, it can potentially be a “cure” for some patients, who will not need the drug after certain period of intake. Existing drugs only lower3 blood sugar when the need arises.Since dorzagliatin is supposed to “repair” patients’ damaged insulin regulating function, it can potentially be a “cure” for some patients, who will not need the drug after certain period of intake. Existing drugs only lower3 blood sugar when the need arises. SCMP Eric Ng - Why are investors offloading Hua Medicine stock which is close to launching a novel diabetes drug?
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Robert Vienneau writes Austrian Capital Theory And Triple-Switching In The Corn-Tractor Model
Mike Norman writes The Accursed Tariffs — NeilW
Mike Norman writes IRS has agreed to share migrants’ tax information with ICE
Mike Norman writes Trump’s “Liberation Day”: Another PR Gag, or Global Reorientation Turning Point? — Simplicius
SCMP
Eric Ng - Why are investors offloading Hua Medicine stock which is close to launching a novel diabetes drug?